Copyright
        ©The Author(s) 2015.
    
    
        World J Gastroenterol. Oct 7, 2015; 21(37): 10584-10597
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10584
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10584
            Table 1 Genes upregulated in hepatocellular carcinoma; putative oncogenes
        
    | Symbol (location) | Biological function | Expression | n | Relevant clinical factors | Functional analyses | Interacting molecules | In vivo | Ref. | 
| AURKA (20q13) | Cell cycle-regulated kinase | IHC | 44 | OS, RFS, number, stage | Chemoresistance, apoptosis | NF-κB, miRNA-21, PTEN | Yes | 40 | 
| BIRC7 (20q13.3) | Inhibitor of apoptosis protein family | mRNA, IHC, WB | 61 | None | Proliferation, migration, invasion, apoptosis | CDK | - | 21 | 
| Brachyury (6q27) | Embryonic nuclear transcription factor | mRNA, IHC | 112 | OS, size, stage | Migration, invasion | PTEN, Akt, Snail, EMT | - | 22 | 
| CCL20 (2q36.3) | Cytokine displaying chemotactic activity for lymphocytes | IHC | 62 | OS, RFS, AFP, size, mumber, vascular invasion, differentiation | Proliferation, migration | pAKT, β-catenin, EMT | - | 45 | 
| CCT8 (21q22.11) | Transport and assembly of newly synthesized proteins | IHC | 102 | OS, grade, size | Proliferation, cell cycle | - | - | 30 | 
| CTSL (9q21.33) | A lysosomal cysteine proteinase for intracellular protein catabolism | mRNA, IHC, WB | 82 | OS, RFS, stage, differentiation | Proliferation, tumorigenesis | - | Yes | 36 | 
| CYTH3 (7p22.1) | Mediator of protein sorting and membrane trafficking | mRNA, IHC | 202 | OS, size, vascular invasion | Proliferation, migration | - | - | 24 | 
| DLX4 (17q21.33) | Forebrain and craniofacial development | mRNA, IHC, WB | 226 | OS, size, differentiation, AFP | - | - | - | 27 | 
| GOLPH3 (5p13.3) | Peripheral membrane protein of the Golgi stack regulating Golgi trafficking | mRNA, IHC | 173 | OS, stage | Chemoresistance, apoptosis, angiogenesis, proliferation | NF-κB | Yes | 44 | 
| GSC (14q32.1) | Autoregulatory transcription factor | mRNA, IHC, WB | 112 | OS, distant metastasis | Migration, invasion | EMT | - | 39 | 
| HSF1 (8q24.3) | Heat-shock transcription factor rapidly induced after temperature stress | IHC | 67 | OS | Proliferation | - | - | 34 | 
| IL-6 (7p21) | Cytokine that functions in inflammation and the maturation of B cells | mRNA, IHC, WB, ELISA | 120 | RFS, vascular invasion, number | Stemness | IGFIR, OCT4, NANOG | Yes | 43 | 
| ISG15 (1p36.33) | Chemotactic activity towards neutrophils | mRNA, IHC | 50 | OS, differentiation, distant metastasis | Proliferation, migration | Survivin | Yes | 33 | 
| KPNA2 (17q24.2) | Nuclear transporter of proteins and VJ recombination | mRNA, IHC | 314 | OS, RFS, size | Proliferation, metastasis | PLAG1 | - | 29 | 
| LGALS3 (14q22.3) | Member of the galectin family of carbohydrate binding proteins | mRNA, IHC, WB | 165 | OS, microvessel density | Proliferation, migration, invasion, apoptosis | - | - | 31 | 
| MACC1 (7p21.1) | Regulator of HGF-HGFR pathway | mRNA, IHC, WB | 50 | OS, grade, stage | Proliferation, apoptosis | HGF, c-MET, PI3K, AKT, Caspase 9 | Yes | 47 | 
| MAGED2 (Xp11.21) | Promotor of the cancer cell adhesion to the vascular epithelium | mRNA, IHC | 151 | OS | - | - | - | 51 | 
| MAGED4 (Xp11.22) | Unknown | mRNA, IHC | 94 | OS, RFS, AFP, vascular invasion, differentiation | - | - | - | 50 | 
| MCT4 (17q25) | Catalyzing lactic acid and pyruvate transport across plasma membranes. | IHC | 318 | OS, RFS, AFP, size | Proliferation, migration, invasion | pAKT, HIF-1α | - | 26 | 
| MRC2 (17q23.2) | Extracellular matrix remodeling by mediating the internalization | IHC | 96 | OS, number, vascular invasion | Migration, invasion | TGFb | - | 25 | 
| PDGFRα (4q12) | Cell surface tyrosine kinase receptor for platelet-derived growth factor family | mRNA | 57 | OS, RFS, vascular invasion, microvessel density | Proliferation, migration, invasion | EMT | Yes | 38 | 
| PKM2 (15q22) | Pyruvate kinase generating ATP and pyruvate | mRNA, IHC, WB | 721 | OS, RFS, size, vascular invasion, differentiation | Proliferation, migration, invasion | pAKT, HIF-1α | Yes | 46 | 
| PLK1 (16p12.2) | Controlling mitotic entry, centrosome maturation, and bipolar spindle formation | IHC | 67 | Differentiation, capsule invasion | Proliferation, cell cycle, apoptosis | caspase 3/8, Bax, Bcl-2 | - | 37 | 
| PTP4A1 (6q12) | Regulator of cellular processes, including cell proliferation and migration | IHC | 167 | OS | Migration, invasion | PI3K/AKT/ GSK3β pathway | - | 32 | 
| SERPINB3 (18q21.3) | Ovalbumin family of serine proteinase inhibitors | mRNA, IHC | 67 | RFS | - | HIF-2α | - | 41 | 
| SIRT1 (10q21.3) | Regulating epigenetic gene silencing and suppress recombination of rDNA | mRNA, IHC, WB | 99 | OS, size, number, stage | Migration, invasion | EMT | Yes | 28 | 
| mRNA | - | - | Proliferation, cell cycle | miR29c | - | 58 | ||
| IHC | 248 | RFS | Proliferation, cell cycle | p53, AMPK, mTOR | - | 59 | ||
| TPX2 (20q11.2) | Microtubule organization during mitosis | mRNA, IHC | 130 | OS, RFS, stage, number, differentiation | Migration, invasion | MMP2/9, pAKT | - | 35 | 
| mRNA, IHC | 86 | OS, RFS, vascular invasion, stage | Proliferation | Yes | 62 | |||
| TREM1 (6p21.1) | Receptor belonging to the Ig superfamily that is expressed on myeloid cells | mRNA, IHC, WB | 322 | OS, RFS, age, AFP | Proliferation, invasion, cell cycle, apoptosis | IL-1β, TNF-α, MCP-1, p65, STAT3, ERK | - | 23 | 
| UBE2Q1 (1q21.3) | Member of the E2 ubiquitin-conjugating enzyme family | IHC | 86 | OS, grade | Proliferation, cell cycle | p53, p21 | - | 42 | 
| UBE4B (1p36.3) | Conjugation factor E4 involved in multiubiquitin chain assembly | mRNA, IHC, WB | 149 | OS, grade, stage | Proliferation, migration, invasion, apoptosis | p53, Bcl-2, caspase 3 | - | 48 | 
| VEGF-B (11q13) | Regulator of angiogenesis | mRNA | 48 | Number, vascular invasion, capsule invasion, stage | - | - | - | 12 | 
| YY1AP1 (1q22) | Unknown | Microarray | 76 | OS | Proliferation, apoptosis, spheroid-formation | EpCAM | Yes | 49 | 
            Table 2 Genes suppressed in hepatocellular carcinoma; putative tumor suppressors
        
    | Symbol (location) | Biological function | Expression | n | Relevant clinical factors | Functional analyses | Interacting molecules | In vivo | Ref. | 
| ARNT2 (15q24) | Partner for several sensor proteins of the bHLH-PAS family | IHC | 195 | OS, RFS, age, size, number, vascular invasion, AFP, differentiation, stage | Proliferation, invasion, migration | - | Yes | 79 | 
| BTG1 (12q22) | Regulates cell growth and differentiation | mRNA, IHC | 151 | OS, RFS, PIVKA-II, size, differentiation, vascular invasion, stage, extra-hepatic recurrence | - | - | - | 80 | 
| CDH3 (16q22.1) | Calcium-dependent cell-cell adhesion glycoprotein | IHC | 69 | Stage | Proliferation | - | - | 71 | 
| EBP1 (12q13.2) | RNA-binding protein involved in cell growth regulation | IHC, WB | 103 | OS, grade, size | Growth, cell cycle | - | - | 74 | 
| FBLN5 (14q32.1) | Secreted extracellular matrix protein | mRNA, IHC | 86 | OS, number, vascular invasion, grade, stage | Migration, invasion | MMP7 | - | 76 | 
| Fbxw7 (4q31.3) | Ubiquitin-mediated degradation of cyclin E | IHC | 60 | OS, size, vascular invasion, grade, stage | Growth, apoptosis | YAP | Yes | 77 | 
| GPx3 (5q23) | Detoxification of hydrogen peroxide | mRNA, IHC, ELISA | 113 | OS, RFS, size, number, vascular invasion, stage | Proliferation, invasion | Erk, NFκB, SIP1 | Yes | 75 | 
| IGFBP-1 (7p12.3) | Mediator of the IGFs | IHC | 90 | OS, differentiation, cirrhosis, vascular invasion, stage | Invasion | MMP9 | - | 73 | 
| LGALS4 (19q13.2) | Modulating cell-cell and cell-matrix interactions | mRNA, IHC, ELISA | 201 | Size, differentiation, vascular invasion, stage | Migration, invasion | - | - | 72 | 
| TIPE1 (19p13.3) | Unknown | IHC | 50 | OS, grade | Growth, apoptosis | Nec-1, Rac-1 | Yes | 78 | 
            Table 3 Genes epigenetically suppressed in hepatocellular carcinoma through promoter hypermethylation
        
    | Symbol (location) | Biological function | Expression | n | Relevant clinical factors | Functional analyses | Interacting molecules | In vivo | Ref. | 
| CLDN3 (7q11.23) | Integral membrane protein and a component of tight junction strands | mRNA, IHC | 114 | OS | Motility, invasion, tumor formation | Wnt, EMT, β-catenin | Yes | 99 | 
| DENND2D (1p13.3) | Membrane trafficking protein regulating Rab GTPases | mRNA, IHC | 92 | OS, RFS | - | - | - | 100 | 
| DPT (1q12-q23) | Cell-matrix interactions and matrix assembly | mRNA, IHC, WB | 202 | OS, RFS, AFP, vascular invasion, differentiation | Migration, metastasis | RhoA, FAK, c-SRC, α3β1 integrin | Yes | 98 | 
| DPYSL3 (5q32) | Cell-adhesion factor involved in the metastatic process of tumor cells | mRNA, IHC | 151 | OS, RFS, AFP, PIVKAII, gender, vascular invasion, serosal invasion | Migration, invasion | VEGF, FAK | - | 105 | 
| EFEMP1 (2p16) | Extracellular matrix glycoproteins | mRNA | 48 | OS, liver damage, AFP | - | - | - | 103 | 
| FBLN1 (22q13) | Secreted fibrillar extracellular matrix protein | mRNA, IHC, WB | 48 | number, size, stage | - | - | - | 96 | 
| MEG3 (14q32) | Unknown | mRNA | 72 | OS, RFS, tumor size and Edmondson grade | Proliferation, apoptosis | p53, UHRF1 | Yes | 102 | 
| MT1G (16q13) | Preserve the homeostasis of metals | mRNA | 48 | none | - | - | - | 11 | 
| PDSS2 (6q16.3-21) | Synthesis of coenzyme Q10 | mRNA, IHC | 151 | OS, RFS, AFP, vascular invasion, differentiation, serosal invasion, stage | - | HNF4a, CDX2 | - | 101 | 
| RELN (7q22) | Secreted extracellular matrix protein | mRNA | 48 | RFS | - | - | - | 104 | 
| TIF1γ (7p22.1) | Unknown | IHC, WB | 204 | OS, RFS, stage | Invasion, metastasis | TGF-β/Smad | - | 97 | 
| TUSC1 (9p21.2) | Unknown | mRNA, IHC | 94 | OS, stage | - | - | - | 106 | 
            Table 4 Dysregulated microRNAs in hepatocellular carcinoma
        
    | microRNA | Sample | n | Relevant clinical factors | Functional analyses | Interacting molecules | In vivo | Ref. | 
| miR-9 | Tissue | 200 | OS, vascular invasion, stage | - | - | - | 122 | 
| miR-21 | Tissue | 109 | RFS, cirrhosis, stage | Growth | AP-1 | Yes | 129 | 
| miR-106b | Tissue | 104 | OS, size, vascular invasion | - | - | - | 125 | 
| miR-122, miR-29 | Serum | 20 | Liver damage | - | - | - | 127 | 
| miR-128-2 | Tissue, serum | 182 | OS, liver damage | - | - | - | 132 | 
| miR-130a | Tissue | 102 | OS, gender, HBsAg status, size, stage | - | - | - | 124 | 
| miR-130b | Tissue | 97 | OS, RFS, HBsAg status, AFP, size, grade, stage | - | - | - | 126 | 
| miR-138 | Tissue | 180 | OS, stage, vascular invasion, stage | - | cyclin D3 | - | 130 | 
| miR-148a | Tissue | 297 | OS, size | Proliferation, migration, invasion | ACVR1, BMP, Wnt | Yes | 131 | 
| miR-224 | Tissue | 130 | OS, RFS, AFP, stage, grade | - | pAKT | - | 128 | 
| miR-331-3p | Tissue | 108 | OS, RFS, size, number, vascular invasion | Proliferation, migration, metastasis | PHLPP, AKT, EMT | Yes | 123 | 
- Citation: Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10584-10597
- URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10584.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i37.10584

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        